Guanidinoacetic Acid With Creatine Compared With Creatine Alone for Tissue Bioenergetics, Hyperhomocysteinemia and Exercise Performance
1 other identifier
interventional
14
0 countries
N/A
Brief Summary
Co-administration of creatine and guanidinoacetic acid (GAA) has been recently put forward as an advanced dietary strategy to optimize tissue bioenergetics. The investigators hypothesized that creatine-GAA mixture would result in more powerful rise in brain and skeletal muscle creatine, as compared to creatine supplementation alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedFirst Submitted
Initial submission to the registry
November 17, 2017
CompletedFirst Posted
Study publicly available on registry
November 22, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedMay 4, 2018
May 1, 2018
1.4 years
November 17, 2017
May 3, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Brain creatine
Rise in brain creatine levels
Baseline vs 4-week follow up
Secondary Outcomes (1)
Vastus medialis creatine
Baseline vs 4-week follow up
Study Arms (2)
Mixture GAA-creatine
EXPERIMENTALMixture of guanidinoacetic acid and creatine monohydrate
Creatine
ACTIVE COMPARATORCreatine monohydrate
Interventions
Eligibility Criteria
You may qualify if:
- men age 18-45 years
- BMI 18.5-24.9 kg/m2
- physically active (\> 150 min per week)
- free of known disease
- must be able to give written informed consent
You may not qualify if:
- serum homocysteine \> 15 µmol/L
- use of dietary supplement (\> 1 month)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Ostojic SM. Co-administration of creatine and guanidinoacetic acid for augmented tissue bioenergetics: A novel approach? Biomed Pharmacother. 2017 Jul;91:238-240. doi: 10.1016/j.biopha.2017.04.075. Epub 2017 Apr 28.
PMID: 28460226BACKGROUNDSemeredi S, Stajer V, Ostojic J, Vranes M, Ostojic SM. Guanidinoacetic acid with creatine compared with creatine alone for tissue creatine content, hyperhomocysteinemia, and exercise performance: A randomized, double-blind superiority trial. Nutrition. 2019 Jan;57:162-166. doi: 10.1016/j.nut.2018.04.009. Epub 2018 May 17.
PMID: 30170305DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Sergej Ostojic, MD, PhD
University of Novi Sad
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 17, 2017
First Posted
November 22, 2017
Study Start
December 1, 2016
Primary Completion
May 1, 2018
Study Completion
May 1, 2018
Last Updated
May 4, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Data will be available from January 2018
The data will be shared via institutional repository